Sep 22, 2022 / 02:30PM GMT
Operator
Good morning, and welcome to the CymaBay Therapeutics Analyst Day. (Operator Instructions) As a reminder, this call is being recorded and a replay will be made available on the CymaBay website following the conclusion of the event.
I'd now like to turn the call over to your host, Sujal Shah, President and CEO of CymaBay Therapeutics. Please go ahead, Sujal.
Sujal A. Shah - CymaBay Therapeutics, Inc. - President, CEO & Director
Thank you, [Jerah]. Welcome and thank you to all who have joined us today. It's really been an exciting time in the field of PBC over the last few years. And it's an exciting time for CymaBay, where we are centrally focused on patients with PBC today. On the heels of completing enrollment in response, our global Phase III registration study of seladelpar in PBC, it's fitting that we're here today during PBC Awareness Month, with an opportunity to talk to you all about a potential near-term opportunity we believe we have to significantly advance the care for patients suffering from PBC.
Next. Now before we begin, I'll
Cymabay Therapeutics Inc Analyst Day Transcript
Sep 22, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers